× Business
TelecomHealthcareDigital MarketingERPRetailMedia and EntertainmentOil and GasFood and BeveragesMarketing and AdvertisingBanking and InsuranceMetals and MiningLegalComplianceCryptocurrency
Big DataCloudIT ServiceSoftwareMobileSecurityNetworkingStorageCyber SecuritySAPData AnalysisloTBio TechQuality AssuranceEducationE-commerceGaming and VFXArtificial Intelligencescience-and-technology
Cisco DATABASE Google IBM Juniper Microsoft M2M Oracle Red hat Saas SYMANTEC
CEO ReviewCMO ReviewCFO ReviewCompany Review
Startups Opinion Yearbook Readers Speak Contact Us

10 Fastest Growing Pharma Companies 2016

Orchid Chemicals & Pharmaceuticals Ltd.: A vertically integrated pharmaceutical company with established capabilities across multi-therapeutic domains


"The best way to find yourself  is to lose yourself in the service of others.” – Mahatma Gandhi

An Export-Oriented Unit (EOU), Orchid Chemicals & Pharmaceuticals Ltd. was established in 1992. (Orchid) is a vertically integrated company spanning the entire pharmaceutical value chain from discovery to delivery with established credentials in research, manufacturing and marketing. Today, they are ranked amongst the top 15 pharmaceutical companies in India and enjoy a multi-therapeutic presence across segments like anti-infectives, anti-inflammatory, Central Nervous System (CNS), Cardio Vascular Segment (CVS), Nutraceuticals and other oral and sterile products. Their pharmaceutical solutions include active pharmaceutical ingredients (API), finished dosage forms, New Drug Discovery (NDD), Novel Drug Delivery Systems (NDDS) and Contract Research And Manufacturing Services (CRAMS).

They are globally present across 70+ countries through alliances, joint ventures and partnerships with globally reputed majors.

Their integrated business model enables them to cater to business opportunities throughout the value chain, from research to delivery of drugs across therapeutic segments. Also, their niche product basket helps them to maintain an edge over peers in the markets where they are present. In the years to come, driven by a highly competent and motivated team, the company strives to move from strength to strength in the key domains of API, global generics and drug discovery.

Our vision is to enrich lives through Innovation in Healthcare

Orchid’s Unique Philosophy

Valuing People
Their unique “People and Process Paradigm” helps achieve the twin objective – emphasis on regulatory and compliance on one hand, while fostering – innovation and creativity on the other.

Peak Performance
They continuously seek to build a sustainable organizational eco-system where one is constantly motivated to attain new heights and empowered to discover new avenues for growth.

Quality has always been a strong part of Orchid’s proposition. Their quality initiative covers all aspects including product quality, operational quality, environmental quality and finally a good quality of life for their people.

Harmony with Society
They seek to balance environmental impact and economic interest in all business activities. Committed to the development of the society, culture and economy, they dutifully observe laws; demonstrate high ethical standards and endeavour to preserve the environment.

Products range
Regarded as one of the youngest pharmaceutical company in India to receive the coveted ISO Certification, the products offered by Orchid are of world-class quality products and facilities, regulatory and compliance systems conform to international standards.

Product range of Orchid is categorized under two sections namely Formulations (Domestic) and API. Under Formulations (Domestic) comes Cardiovascular, Anti-Diabetic, Neuropsychiatry, Nutritional Supplements and few others. Whereas, API encompasses Cephalosporins – Orals, Cephalosporins – Injectibles, Veterinary Products and Non-Antibiotics.

Delivering Best-in-Class ‘Quality’ is their motto
The company accord’s the highest emphasis to quality and it is given as much attention as innovation and value creation. A fully computerized quality control system monitors operations round-the-clock thereby ensuring highest standards of quality.

At Orchid, maintaining highest levels of quality helps them to deliver excellence in everything they do reflecting not only in robust growth but also in personal development and enhanced management abilities.

Their manufacturing facilities deploy state-of-the-art technologies and automated facilities that ensure the highest levels of process integrity and product quality. Their facilities have fully self-reliant Quality Control departments with sophisticated equipment such as HPLCs, GCs, titrators, FTIRs and UV spectrometers to ensure conformance to stringent quality standards.


“Since our inception, we are incorporated as a 100 percent export oriented unit (EOU). These 20 years have seen us evolve as a global leader in the pharmaceuticals business, with a technology profile, quality level and growth that have little parallel in the Indian pharmaceutical industry. This evolution is reflected in our multi-tier integration encompassing APIs and dosage forms for regulated and emerging markets, drug discovery and drug delivery system, capturing all the critical dimensions of the value.

We have always countered challenges successfully with our operational efficiency and best management of Human Capital. Talent management and talent transformation hold the key to Orchid’s business development. We also believe that transparency in sharing of information and quantification of shareholder value goes a long way in strengthening the relationship between the stakeholders and the company.” – K. Raghavendra Rao, Managing Director.

Knowing the Thought Leader

Shri K. Raghavendra Rao, Managing Director – Carrying a Bachelors Degree in Commerce from Andhra University and a Post-Graduate Diploma in Management from IIM-Ahmedabad, Raghavendra is also a member of The Institute of Cost & Works Accountants of India and The Institute of Company Secretaries of India. He is the Founder and Managing Director of Orchid. Prior to establishing Orchid, he was associated with leading organisations in India in various capacities. He was singularly responsible for developing a multi-business conglomerate in the Gulf, which included the region’s first ever bulk drugs plant.

“We successfully leverage our penchant for science and technology to create niche products and manufacturing platforms leading to attractive growth”